Department of Bioengineering and Therapeutic Sciences

The statutory requirement for substantial evidence of effectiveness of a new drug has generally been interpreted to require demonstration of a low probability (p<0.05), assuming non-effectiveness, based on data from two phase III clinical trials.

UC San Francisco today announced the establishment of the Quantitative Biosciences Institute (QBI).

The UCSF School of Pharmacy’s doctor of pharmacy (PharmD) program is among the top-ranked programs in the 2017 U.S. News and World Report survey of accredited PharmD programs released on March 15, 2016.

A five-day fundamentals course emphasizing basic principles in pharmacokinetics. This is an annual course now in its 29th year.

The Troy C. Daniels Curricular Innovation Awards provide funds in 2016 to support the evolution of the UCSF School of Pharmacy doctor of pharmacy (PharmD) curriculum to prepare leaders for a changing health care marketplace.

The Mary Anne Koda-Kimble Seed Award for Innovation funds “truly innovative projects” by faculty, staff, and students that “have the potential to move forward the mission of the UCSF School of Pharmacy in new ways.”

We are thrilled to announce that Michael Fischbach and Xin Chen have won prestigious Apple Teaching Awards for Fall 2015.